We propose a new mathematical model to infer capillary leakage coefficients from dynamic susceptibility contrast MRI data. To this end, we derive an embedded mixed-dimension flow and transport model for brain tissue perfusion on a sub-voxel scale. This model is used to obtain the contrast agent concentration distribution in a single MRI voxel during a perfusion MRI sequence. We further present a magnetic resonance signal model for the considered sequence including a model for local susceptibility effects. This allows modeling MR signal-time curves that can be compared to clinical MRI data. The proposed model can be used as a forward model in the inverse modeling problem of inferring model parameters such as the diffusive capillary wall conductivity. Acute multiple sclerosis lesions are associated with a breach in the integrity of the blood brain barrier. Applying the model to perfusion MR data of a patient with acute multiple sclerosis lesions, we conclude that diffusive capillary wall Common indicators derived from such models are the cerebral blood volume (CBV ), 52 the cerebral blood flow (CBF ), the mean transit time (MTT ), and leakage 53 coefficients [10, 12, 19] .
conductivity is a good indicator for characterizing activity of lesions, even if other patient-specific model parameters are not well-known.
Author summary
The use of advanced brain imaging techniques has supported in-vivo research targeted to the integrity of the blood-brain barrier. We propose a new type of post-processing for raw image data using contrast agent perfusion simulations on the data-poor capillary scale. Combining modern simulation techniques with the clinical image data allows us C a (t) sequence is post-processed to provide indicators within regions of interest to the 37 radiologist. Two typical signal intensity-time curves from the brain white matter, with 38 the characteristic first pass signal dip, are shown in Figure 1 . Mathematical models 39 (forward model ) for contrast agent perfusion in the brain tissue can help understanding 40 the underlying reasons for a particular intensity-time curve of a voxel, by identifying 41 and analyzing the model parameters which are able to reproduce the MRI data. This 42 process is also known as solving the inverse problem. To this end, the model parameters 43 are tuned by using parameter estimation techniques. Forward models are typically 44 based on a two-compartment pharmacokinetic tracer model and are parameterized by a 45 small number of parameters [14] [15] [16] . Figure 2 visualizes a two-compartment model 46 conceptually, with compartments representing plasma and extra-vascular, extra-cellular 47 space. The plasma compartment is supplied by a flux determined by an arterial input 48 function (AIF ) [17] . The AIF can be estimated from voxels that are mostly constrained 49 within a larger afferent artery [18] . The plasma compartment exchanges mass with the 50 extra-vascular, extra-cellular space proportionally to its permeability-surface product.
µ B = 0.001 · 220 · e −2.6R −2.44 · e −0.06·(2·R) 0.645 +3.2 Pa s.
The effective vessel radius, R, is chosen with respect to the cross-section area, 110 A v = πR 2 . Blood density is assumed constant, ρ B = 1050 kg m −3 [39] . Under these 111 assumptions, the flow in the lumen of a capillary vessel can be described by
where M c is the molar mass of the contrast agent, ρ m,B the molar density of blood, and 121 
where χ(r), φ(r) are the dimensionless velocity profile and the dimensionless 126 concentration profile, respectively. As it has been observed that small nano particles are 127 likely to be distributed evenly [40] , we choose ω = 1.
128 radius, r hy = 0.9 nm [42] , 138 D c B = k B T 6πµ P r hy ≈ 1.9 · 10 −10 m 2 s −1 ,
where µ P = 1.32 Pa s [43] denotes the blood plasma viscosity, T the temperature in K, 139 and k B the Boltzmann constant. The extra-vascular compartment is modeled as a porous medium with a rigid solid 142 skeleton, consisting of cells, fibers, and extra-cellular matrix. Flow of a single fluid 143 phase, the interstitial fluid, through a porous medium is described by Darcy's law [44] 144
where ρ I , µ I are density and viscosity of the interstitial fluid, v t the filter velocity 
where φ denotes the porosity, the ratio of pore volume to total volume in a 153 representative elementary volume, ρ m,I the molar density of the interstitial fluid 154 solution, D e is the effective diffusion coefficient, and q c (kg s −1 m −3 ) is the contrast 155 agent mass exchange with the vascular compartment. We assume that the interstitial 156 space in the extracellular matrix, with pore throat diameters of around 50 nm [26] , still 157 allows for a viscous flow regime. Furthermore, it is assumed that Gadobutrol will not 158 enter cells. The effective diffusion coefficient in the porous medium can be estimated as 159 D e = τ φD c I , where τ denotes the tortuosity of the extra-cellular matrix, and D c I the 160 binary diffusion coefficient of contrast agent in interstitial fluid, for which we choose the 161 same value as for the binary diffusion coefficient of contrast agent in plasma Eq. (5).
162
Following the literature for tortuosity and porosity values [26] , we choose τ = 0.4 and 163 φ = 0.2, which yields, D e ≈ 1.5 · 10 −11 m 2 s −1 .
164
Transmural exchange 165 The wall of continuous capillaries consists of an endothelial surface layer, a basal 166 membrane, and a layer of charged proteins, called glycocalyx [46, 47] . Mass exchange 167 can occur passively through the endothelial tight junctions, or through trans-cellular 168 pathways. Here, we consider only transport by advection and diffusion, following [39] .
169
Given a blood vessel volume fraction of 3 %, an average thickness of the endothelial 170 surface layer of 1 µm [48] , and an average vessel radius of 10 µm, the volume fraction of 171 the capillary wall is less than 1 % of the tissue volume. The capillary wall can be 172 conceptually reduced to a two-dimensional interface, denoted by Γ, separating the 173 vascular from the extra-vascular compartment. Note that this results in a pressure jump 174 across Γ, which is inversely proportional to wall permeability and wall thickness.
175
According to Starling's hypothesis [49, 50] , the transmural flux of a fluid is proportional 176 to the hydrostatic and colloid osmotic pressure gradient between capillary lumen and 177 interstitial space
where L p is the filtration coefficient, with units of m Pa −1 s −1 , S = 2πR is the 179 circumference of the vessel,
is the average hydrostatic pressure on the vessel wall, π v , π t , denote the osmotic 181 pressure in capillary lumen and interstitial space, respectively, and 0 ≤ σ ≤ 1 is the 182 osmotic reflection coefficient. The difference in osmotic pressure results from large 183 plasma proteins in the blood stream, such as albumin, and effectively draws fluid into 184 the vessels. For the in silico experiments, we assume the osmotic pressures to be 185 constant, with ∆π = π v − π t = 2633 Pa [51] . Furthermore, we choose σ = 1, corresponding to the vessel wall modeled as a perfect selectively permeable membrane. 187
The contrast agent is assumed to be transported by advection with the plasma, as 188 well as by molecular diffusion. The reduction of the vessel wall to a surface leads to a 189 concentration jump across the vessel wall, which is inversely proportional to diffusive 190 wall conductivity and wall thickness. The transmural transport is described as [50] 191
where D ω is the diffusive wall conductivity, with units of m s −1 ,
is the average contrast agent mole fraction on the vessel wall,
denotes the mole fraction in upwind direction, and 0 ≤ σ c ≤ 1 denotes the solvent-drag 194 reflection coefficient. As the considered contrast agent is a small molecule and the 195 endothelial tight junctions are damaged in lesion tissue, we set σ c = 0, neglecting 196 reflection. Determining D ω from MRI data is the major objective of this work.
197
The mass balance Eqs. (2), (3), (6) and (7) are coupled by Eqs. (8) and (10), 198 whereas Eqs. (6) and (7) are described in the three-dimensional extra-vascular domain 199 Ω, while Eqs. (2) and (3) are associated with the one-dimensional vascular domain Λ. 200 We follow the concept suggested in [28] : if the source terms,q m ,q c , are defined as line 201 sources along the vessel center line in the three-dimensional domain, while the 202 three-dimensional quantities, p t , x t , are evaluated as the average values on Γ, then, the 203 resulting exchange term is a good approximation of the source term in a non-reduced 204 three-dimensional setting. To this end, we define q m , the source term in Eq. (6), as
so that q m is a line source restricted by the Dirac delta function δ Λ to the center line of 206 December 20, 2018 10/45 a vessel. Analogously, we set q c = −q c δ Λ , for the source term in Eq. (7) .
207
Vessel geometry, boundary conditions and initial conditions 208
The capillary network grid extracted from measurements in the rat cortex [34, 52] and the Cartesian computational grid for the extra-vascular domain, used for the model analysis in this study. The tubes are scaled with the respective vessel radius. The color visualizes hydraulic pressure from high (red) to low (blue). The cones indicate the flow direction.
We base our vascular model on a small network of capillaries from the superficial 209 cortex of the rat [34, 52] , which we consider a sufficient approximation of the actual 210 capillary network geometry for type of model analysis presented in this work. The 211 network has the dimensions 150 µm × 160 µm × 140 µm, and is shown in Fig. 3 . The 212 location of inflow and outflow boundaries are given in this data set. For the inflow 213 boundaries, [34] provide velocity estimates based on the vessel radius, which are applied 214
as Neumann boundary conditions. At the outflow boundaries, we enforce Dirichlet 215 boundary conditions for the pressure, p v,out = 1.025 · 10 5 Pa.
216
The domain initially contains no contrast agent, so that x v (x, t) = 0. During the 217 perfusion MR study, 10 ml contrast agent (0.1 mmol per kg body weight) is 218 administered intravenously as a solution at 5 ml s −1 and a concentration of 1 mol l −1 .
219
The injected fluid thus forms a sharp bolus. However, the bolus disperses significantly 220 before it reaches the brain capillaries. Therefore, the concentration inflow profile to the 221 capillary network has to be estimated from the parameters of the bolus injection. To this end, we use an ansatz from [22] 223 parameter values are patient-specific and also depend on the location in the brain.
230
Values for a,b, and t p are discussed below, in the context of parameter estimation. assuming that the modeled domain is surrounded by domains with similar properties.
236
Mixed-dimension embedded model for tissue perfusion 237 In summary, the complete coupled fluid mechanical model of tissue perfusion reads as: 238
then find x t ,x v such that This fast imaging technique allows acquisition of an entire brain image stack in less than 250 two seconds. Thus, after the injection of a contrast agent, a time series of such images 251 can be acquired, where the characteristic signal-time curve for every voxel is dependent 252 on the evolution of the contrast agent concentration distribution on the meso-scale.
253
The GRE-EPI sequence starts with a radio frequency (RF ) pulse, which reorients times, T 1 , T * 2 , relaxes the magnetization into the initial state aligned with B 0 .
258
According to [22] , the GRE-EPI voxel signal during a DSC-MRI perfusion sequence can 259 be modeled as 260
where the repetition time T R , is the time between two RF pulses, and the effective echo 261 time, T E , is the time between RF pulse and signal readout. The base signal S 0 > 0 262 depends, i.a., on tissue proton density and the MR scanner hardware. In the following, 263
we look only at the normalized signal S n (t) = S(t)S −1 pre , where S pre is the signal before 264 the contrast agent bolus arrives in the tissue sample. The pre-contrast signal, S pre , contains all constant factors in Eq. (17), including S 0 . It follows from Eq. (17) that a 266 shortening of T * 2 results in a decrease of NMR signal strength, while a shortening of T 1 267 results in signal enhancement.
268
The following two sections introduce the models for the relaxation rates
that depend on the spatial and temporal evolution of the contrast agent sub-voxel distribution of the contrast agent concentration. We follow [22] , to develop a 276 model considering the spatial and temporal distribution of the contrast agent.
277
Transversal relaxation in tissues with locally heterogeneous microstructure 278
The transversal relaxation rate, R * 2 , depends on the complex local microstructure of the 279 tissue [24] and is altered by the presence of the contrast agent. We are only interested 280 in the signal change relative to the baseline, so we split the relaxation rate in a static 281 pre-contrast contribution and a time-dependent contribution depending on the contrast 282 agent concentration,
The relaxation rate for a sub-voxel control volume can be described by contributions 284 of three compartments, the vascular compartment (B), the extra-cellular, extra-vascular 285 space (I), and the cellular compartment (S), weighted by their volume fractions, φ B , φ I , 286
According to [25] , the rate in each compartment κ ∈ {B, I, S}, comprises 288 contributions on three spatial scales
The rate R * 2,macro describes effects of static local inhomogeneities of the magnetic field 290 B 0 , which are time-independent. Since the static effects do not depend on the contrast 291 agent concentration, they are included in the pre-contrast relaxation rate, R * 2,pre . The 292 rate R * 2,κ,micro depends on the local chemical composition. The effects are independent 293 of the pulse sequence. Gadolinium-based contrast agent molecules increase the 294 relaxation rate, which can be described by a linear relationship [25] ,
where r 2 is the molar relaxivity, and c κ the local contrast agent concentration in 296 compartment κ. The molar T 2 relaxivity, r 2 , of Gadobutrol at 3 T and 37 • C is 297 approximately 3.9 m 3 mol −1 s −1 [53] . Here, we assume that the contrast agent cannot 298 enter the cells, c S = 0, hence R * 2,S,micro = 0.
299
The term R * 2,meso stems from a meso-scale effect. The magnetic field perturbations 300 induced by the difference in magnetic susceptibility in the blood vessel and the 301 extra-vascular space, increase the relaxation rate of the extra-vascular space in 302 proximity of a blood vessel. The generated magnetic field perturbations are several 303 orders of magnitude smaller than B 0 . Furthermore, the influence decays rapidly with 304 distance to the vessel surface. Therefore, we consider each segment of the vessel network 305 to cause a perturbation independent of the other segments. The increase in R * 2 at a 306 given location in the tissue caused by mesoscopic magnetic field perturbation will then 307 be the superposition of all n segment perturbations
where |c B −c I | is the difference of the concentrations averaged on the vessel surface. The 309
factor κ B ≥ 0 is an ad-hoc parameter, scaling the strength of these perturbations. The 310
proportionality factor ϕ i models the decay of the influence of the with distance from the 311 vessel wall. We set ϕ i = R 2 /r 2 , assuming a quadratic decay, where r is the distance to 312 the vessel center line and R the radius of the vessel segment. The susceptibility contrast 313 likewise increases the transversal relaxation rate, which we model by
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The same effect occurs at the cell surfaces, induced by the difference in magnetic 315 susceptibility between interstitial space and cells. Note that we consider cells not to be 316
invaded by contrast agent. We include this effect by adding a term to Eq. (22),
and to the relaxation rate of the cell compartment,
where κ T ≥ 0 is a second ad-hoc parameter, determining the strength of these 319 perturbations. Furthermore, we assume that there is no direct interface between the 320 cells and the vascular compartment.
321
Combining Eqs. (19) , (21) and (23) to (25), we obtain a formulation for the transversal relaxation rate dependent on the concentration fields and the volume fractions of the three compartments:
Longitudial relaxation with contrast agent administration 322 Similar to T * 2 , the contrast agent also shortens T 1 . However, the effects occur merely on 323 the micro-scale. Thus, we can model the relaxation rate R 1 = 1/T 1 of the tissue sample 324 by 325
where we implicitly assumed that contrast agent does not enter cells, c S (x, t) = 0. The 326 molar T 1 relaxivity, r 1 , of Gadobutrol at 3 T and 37 • C is approximately [53] .
328
Voxel signal 329 The relaxation rates, R * 2 and R 1 (Eqs. (26) and (27) 
where u is the respective discrete primary variable (fluid pressure in Eq. (15) 
where ILU 0 (A) denotes an incomplete LU-factorization of the matrix A using A's 356 sparsity pattern (zero fill-in) [54, Chapter 10] . 357 We assume that the influence of the sub-voxel contrast agent evolution during a 358 single image acquisition on the NMR signal is negligible, and thus, Eq. (17) is solved as 359 a post-processing step after each time step of the perfusion model.
360
The model converges in time and space to a reference solution computed on a very 361 fine grid and a very small time step size. The convergence study is described in detail in 362 S1 Appendix. As a result of the convergence study, we choose our computational grids 363 such that the largest grid cell does not exceed 8 µm. This results in a run-time of a few 364 seconds on a normal laptop for a single forward model run.
365
The model is implemented with the open-source porous media simulator DuMu x [55] , 366 which is based on the Distributed Unified Numeric Environment (DUNE) [56, 57] . The 367
implementation of the mixed-dimension embedded tissue perfusion model is based on a 368 recent extension of DuMu x for multi-domain porous media problems, first described 369 in [58] for the simulation of root-soil interaction in the vadose zone. We refer to this 370 publication for a more detailed description of the discretization, assembly procedure, 371 and software implementation of mixed-dimension embedded models.
372
Inverse modeling using clinical MRI data 373 We use clinical MRI data to evaluate the presented model. We choose a patient with Several model parameters can be assigned a fixed value, either because the parameter 384 assumes a well-known fixed value given in the literature, or because the parameter is not 385 expected to significantly affect the results of this particular study and an approximate 386 value can be obtained from the literature. However, there are also parameters that are 387 inherently patient-specific and cannot be directly measured, or parameters for which the 388 measurement data is not available for the given patient. These parameters are, a, b, t p , 389
Determining these parameters for a given signal-time 390 curve constitutes an inverse problem. In particular, we aim to determine D ω , which 391 may quantify contrast agent leakage, and thus, has direct clinical relevance.
392
In the following, we briefly discuss typical values or value ranges for these 393 parameters. The shape parameters, a, b, t p , determine the inflow profile of the bolus 394 arriving at the voxel under study. They are generally varying from voxel to voxel. In In a preliminary model investigation, we use the parameter estimation toolbox 426 PEST [62] to find the parameter set that minimizes the sum of squared differences, 427 ||E opt || 2 2 , between the simulated signal-time curve and the MRI data. For the parameter 428 estimation, we employ the truncated singular value decomposition algorithm, available 429 in PEST. The estimated parameter values for the best fit against the curves N and L, 430 cf. Fig. 1 , as well as the corresponding ||E opt || 2 , are given in Table 1 .
431
A comparison of the simulated and measured NMR signals, Fig. 4 , indicates that the 432 model can reproduce the measured curves well. Table 1 shows that the diffusive wall 
at the end of the simulation, t end = 112 s. Additionally, we compute the total mass of Simulated normalized NMR signals compared with MRI data (see Fig. 1 ), using the best fit parameter estimates given in Table 1 . Left -the result for the lesion sample (L), right -the result for the NAWM sample (N). Table 1 , this means that there is little to no contrast agent leakage for 450 sample N, while there is significant leakage for sample L. This is in accordance with the 451 present understanding of the pathology, which assumes leaky vessel walls in MS lesions. 452
However, the problem of finding best fit parameters is typically ill-conditioned, or 453 even ill-posed as the solution may be non-unique, such that the employed parameter 454 estimation method may not be reliably applied. Therefore, we discuss other methods to 455 further analyze the model parameters in the subsequent sections.
Parameter sensitivity 457
For a better understanding of the influence of the patient-specific parameters on the stronger than the signal decrease due to T * 2 -shortening, as clearly seen in Fig. 7 . This 487 illustrates that it is essential for the NMR signal model to include meso-scale effects.
488
The scaling parameter κ T for the meso-scale T * 2 -effects from the cell walls, only 489 influences the signal in the presence of leakage (sample L). This is evident, since the 490 difference between the contrast agent concentration in the cells and the extra-vascular, 491 extra-cellular compartment is zero, in the absence of leakage. Fig. 6 
where p(θ|X) is the posterior distribution, i.e. the probability of θ given the observation 519 data X. p(X|θ) is the likelihood function, i.e. the probability of the X being from the 520 same population as the model prediction, given θ. p(θ) is the prior distribution 521 reflecting prior knowledge about the parameters θ, before knowing the observations. 522 p(X) is the marginal likelihood, a normalization constant, not depending on θ. Now, let 523 Y = M(θ) be the model prediction given the the parameters θ. We assume that we can 524
where is the combination of measurement error and unbiased model error and σ its 526 standard deviation. The likelihood that any model answer, Y , comes from the same 527 population as the measurement, X, is a Gaussian likelihood
if the errors of all observations are assumed to be uncorrelated. The standard deviation, 529 σ, has to be estimated for the given MRI data and the proposed model. We assume 530 that our model represents the underlying physical processes accurately, so that model 531 and discretization error are negligible compared to the MRI data measurement error.
532
The measurement error is estimated from the MRI data obtained before the contrast 533 agent bolus reaches the tissue sample, where the measurement is assumed to fluctuate 534 around a constant baseline signal. To this end, we take 100 random signal samples from 535 the brain slice shown in Fig. 1, normalize space, creating a representative set of samples from the posterior distribution, after a 542 sufficient number of iterations. These samples form a Markov chain such that the 543 parameters with which the sample is generated in one step only depend on the 544 parameters in the previous step. Herein, we use the ensemble sampler proposed in [63] , 545 which is implemented in the Python module emcee [64] . Its algorithm features an 546 ensemble of interdependent Markov chains (so called walkers), enabling multiple parallel 547 forward model runs within one step. The algorithm is briefly described in S2 Appendix. 548 We refer to the literature [63, 64] for a comprehensive discussion.
549
In the following, Bayesian parameter inference is used to compute the probability 550 distribution of the patient-specific model parameters, under physical parameter 551 constraints, given a signal-time curve from a voxel of a perfusion MRI sequence. To this 552 end, we choose the prior distributions of the parameters to be uniform distributions 553 within the bounds given in Table 2 . The ensemble sampler is configured with k = 100 554 walkers. The parameter vector is θ = [a, b, t p , log 10 D ω , T 1,pre , κ B , κ T ] T , so that N = 7. 555
The parameter L p remains fixed to reduce the dimension of the parameter space. Its 556 influence on the NMR signal has been shown in the previous section to be significantly 557 weaker than the influence of D ω (see Fig. 6 ).
558
The sampler convergence is estimated using the integrated auto-correlation time, 559 τ f [63] ,
where f = {f i } M i=1 is a finite chain of length M , e.g. the value of parameter a for each 561 sample in the Markov chain, and µ f its arithmetic mean. We use an estimate of the integrated auto-correlation, τ f,e , using the Python module acor [65, 66] . We compute 563 this estimate for the chain of each parameter, θ i , and use the minimum and maximum 564 values, τ max = max 0≤i<N τ θi,e , τ min = min 0≤i<N τ θi,e . The sampler is run until the 565 sample size, j > 100 · τ max , and the change in the auto-correlation time estimate from 566 sample j − τ max to sample j is less than 1 %. The resulting histograms for each 567 parameter and their covariance with respect to the other parameters is visualized in 568 Fig. 8 for sample L and Fig. 9 for sample N (cf. Fig. 1 ). To eliminate artifacts from the 569 burn-in phase of the MCMC algorithm, the first 10 · τ max samples are discarded. To 570 have only independent samples, every τ min sample of the remaining samples is 571 chosen [63] , while the others are discarded. The solid black lines in Figs. 8 and 9 show 572 the parameter values of Table 1 that were obtained previously with PEST.
573
To interpret the results, we recall the original question: What can we learn about the 574 model parameters, given the MRI data?
575
If the posterior distribution of a parameter is close to uniform, i.e. close to the prior 576 distribution (see Table 2 ), the data did not provide any additional information about 577 this parameter. This is the case for κ T and T 1,pre in Fig. 9 , which is consistent with the 578 observation in Fig. 7 that the sensitivity of the NMR curve with respect to changes in 579 κ T or T 1,pre is low.
580
In contrast, if the posterior distribution differs significantly from the prior 581 distribution, the data provides significant information on this parameter. This is the 582 case for the parameters D ω and κ T in Fig. 8 , and D ω and κ B in Fig. 9 . Again, this is 583 consistent with the observation in Figs. 6 and 7 that the sensitivity of the NMR curve 584 with respect to those parameters is high, such that only a small range of values for those 585 parameters is likely to match the model results with the clinical MRI data.
586
Most interestingly, the distribution of D ω in Fig. 8 differs significantly from the 587 distribution of D ω in Fig. 9 . Both distributions are shown as histograms in Fig. 10 . For 588 sample N, the inferred diffusive wall conductivity is very likely to be below Fig. 1, sample L) . The histograms on the diagonal are the histograms for single parameters, the scatter plot in the matrix shows the covariance between the respective row and column parameters (plot generated with [67] ). The histogram titles show median, 5th, and 95th percentile (also visualized as dashed lines). The horizontal and vertical solid black lines show the parameter values for sample L of Table 1 . Histograms of model parameter distributions after learning from MR voxel data from NAWM (see Fig. 1, sample N) . The histograms on the diagonal are the histograms for single parameters, the scatter plot in the matrix shows the covariance between the respective row and column parameters (plot generated with [67] The current model relies on a single exemplary vessel geometry. Today, patient-specific 607 sub-voxel vessel geometries cannot be routinely measured. Hence, the influence of 608 different vessel geometries on the presented results has to be investigated. improved to include re-circulation and to be derived from AIF measurements.
614
The presented model considers processes in a sub-voxel tissue sample that is 615 surrounded by tissue with the same properties. However, contrast-enhancing lesions in 616 the brain typically span over several MRI voxels, see Fig. 1 
In time, we define the maximum relative error over all time steps t i , i ∈ {0, · · · , τ },
671
where τ is the number of time steps, as 672 e u,∞ = max e i u .
Finally, we measure the difference of the signal-time curve, S, to the reference curve,
673
S ref , computed with the finest spatial and temporal discretization, in the following norm 674
The convergence rates for a given error e are computed from one refinement level n 675 to the next as 676 rate = ln e n+1 − ln e n ln ν n+1
where ν max is the respective maximum discretization length. In space, ν max is defined as 677 the maximum edge length of all elements, h max . When refining, the vessel domain grid 678 is also refined by bisecting large elements until the maximum element length is smaller 679 than h max . In time, ν max is defined as the maximum time step size. The time step size, 680 ∆t, is chosen to be small around the time where the contrast agent front reaches the 681 domain, and increasingly larger as the process becomes slower, following the heuristic 682 ∆t = θ ln(t + 1.05),
where θ > 0 is a factor controlling the time step size in the refinement study.
683
The reference solution is obtained with h max = 1 µm and θ = 0.125. The parameters 684 are chosen to be the optimal parameter set computed by an optimization algorithm 685 described in the following section Parameter estimation (see Table 1 signal difference to the MRI data from an MS lesion shown in Fig. 1 (in red).
687 Table 3 show the errors and convergence rates of the extra-vascular fluid pressure, p t , 688
and the contrast agent mole fraction, x t . Fig. 11 shows the NMR signal curves and 689 errors with respect to the reference solution when refining in space and time.
690
It can be seen that all quantities converge to the reference solution. We obtain 691 convergence rates close to 1 for the pressure and the mole fraction of the contrast agent. 692
The signal curve converges with first order in time and a slightly higher order in space. 693
The higher convergence may be explained by the computation of the signal involving 694 the integration of the concentration over the entire domain. The relative error with 695 respect to the reference solution, is smaller than 1 % for a moderate spatial and temporal refinement. In conclusion, we consider a spatial resolution of h max = 8 µm, 697 and a temporal resolution θ = 1 as sufficient for the subsequent analysis. We justify this 698 with the assumption that the errors resulting from model parameter uncertainty, as well 699 as the errors in the measurement data, are larger than the discretization error. This is 700 also evident, when looking at the results of the parameter study and comparing the 701 variability with that of the signal-time curves shown in Fig. 11 for different spatial and 702 temporal discretizations. In order to verify that the discretization error is small also for 703 other parameter configurations, we ran the above analysis for various parameter 
where θ j is a walker position randomly drawn from the positions of the other set of ,
where N = dim(θ) is the dimension of the parameter space. If the sample is not which is computationally the most expensive part. Fortunately, advancing the walkers 719 within a set of walkers can be done in parallel.
720

